Experts Highlight the Most Important Advances in HR+/HER2- Breast Cancer

Gain insights from leading experts on recent key practice-changing data including guidance on incorporating into practice to optimize the care of patients with HR+/HER2- early and metastatic breast cancer through an on-demand webcast and accompanying downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Lilly

Stemline Therapeutics, Inc.